Previous studies have demonstrated that obesity is associated with an increase in OS or BCSS in patients with ER and/or PR positive breast cancer but is not in patients with ER and PR negative breast cancer [1, 4, 10, 11, 14]. Here, ESR1 is linked to obesity due to melanocortin 4 receptor deficiency.